Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease

被引：0
|
作者：
Saleem, R. [1 ]
Dubois, P. [1 ]
Chung-Faye, G. [1 ]
Bjarnason, I. [1 ]
Hayee, B. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60602-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P482
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [31] Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
    Franco Leal, Raquel
    Planell, Nuria
    Kajekar, Radhika
    Lozano, Juan J.
    Ordas, Ingrid
    Dotti, Isabella
    Esteller, Miriam
    Carme Masamunt, M.
    Parmar, Harsukh
    Ricart, Elena
    Panes, Julian
    Salas, Azucena
    GUT, 2015, 64 (02) : 233 - 242
  • [32] ANTI-TNF THERAPY REDUCES IONISING RADIATION EXPOSURE IN PATIENTS WITH CROHN'S DISEASE
    Aggarwal, D.
    Limdi, J. K.
    GUT, 2014, 63 : A79 - A79
  • [33] Anti-TNF therapy use in pregnant patients with Crohn's disease and ulcerative colitis
    Kiely, C.
    Subramaniam, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 104 - 104
  • [34] Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus
    Gonzalez-Lama, Yago
    Ricart, Elena
    Carpio, Daniel
    Bastida, Guillermo
    Ceballos, Daniel
    Ginard, Daniel
    Marin-Jimenez, Ignacio
    Menchen, Luis
    Munoz, Fernando
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [35] FECAL CALPROTECTIN AFTER 3 MONTHS OF ANTI-TNF THERAPY STRONGLY PREDICTS PROLONGED CLINICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE
    Sollelis, Elisa
    Minet-Quinard, Regine
    Bouguen, Guillaume
    Goutte, Marion
    Goutorbe, Felix
    Bouvier, Damien
    Pereira, Bruno
    Bommelaer, Gilles
    Buisson, Anthony
    GASTROENTEROLOGY, 2018, 154 (06) : S825 - S826
  • [36] Anti-TNF treatment of Crohn's disease
    Camoglio, L
    VanDeventer, SJH
    Tytgat, GNJ
    TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 111 - 117
  • [37] Anti-TNF antibodies for Crohn's disease
    Camilleri, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1662 - 1662
  • [38] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [39] Prediction of loss of response to anti-TNF therapy using SES-CD in patients with Crohn's disease
    Fuyuno, Y.
    Torisu, T.
    Hirano, A.
    Fujioka, S.
    Umeno, J.
    Moriyama, T.
    Kitazono, T.
    Esaki, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S211 - S212
  • [40] Anti-TNF Alpha Therapy and Orofacial Crohn's Disease in Pediatrics
    Chapuy, Laurence
    Deslandres, Colette
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S71 - S71
12345